Healthcare | August 08, 2021
Metropolis Healthcare PAT at Rs 74.89 crores for Q1FY22
Board approves fundraise of Rs 1500 crore
Board approves fundraise of Rs 1500 crore
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
In the interim, the statutory approvals obtained by the company under SEBI ICDR have lapsed in accordance with applicable law and are required to be re-obtained
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
The company had filed a suit in the High Court of Justice, Ghana
Tiger can no longer make an important biotin intermediate using a DSM patented process.
Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.
Subscribe To Our Newsletter & Stay Updated
